• {%buzitemName%}
        {%buzbrandMenuItems%}
    • {%bitemName%} {%barrowSpan%}
        {%bsubBrandMenuItems%}
    • {%sbitemName%} {%sbarrowSpan%}
        {%sbproductMenuItems%}
    • {%pitemKeyName%} {%pitemBadges%} {%parrowSpan%}
      {%pselfProduct%}
    • {%mNavitemName%}
      • {%lScountries%}
    • {%allMenuItem%}
      • {%cSlanguages%}
      • Preempt

      Important Information

      • Any reference to the PREEMPT protocol refers to the management of Migraine and is not relevant when considering injections for Movement Disorders.
      • The underlying anatomy content is provided to you following your request to AbbVie for Clinical Specialist training.
      • This material is part of a tailored curriculum developed by AbbVie in collaboration with you, based on the training goals that you have shared with AbbVie.
      • This content is intended specifically for you and must not be shared with other individuals.

      Abbvie Migraine Injection Sites - Trapezius

      Abbvie Migraine Injection Sites - Temporalis

      Abbvie Migraine Injection Sites - Occipitalis

      Abbvie Migraine Injection Sites - Face

      Abbvie Migraine Injection Sites - Cervical Paraspinals

      Abbvie Migraine Injection Sites - Additional Sites

      Abbvie Migraine Injection Sites - Full Version

      This website is intended for Canadian Healthcare Professionals

      Copyright © 2026 AbbVie Corporation. All rights reserved.

      Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.